BRIEF-Alphaton Capital Executes Binding Call Option With Immunova

Reuters

Feb 18

Feb 17 (Reuters) - AlphaTON Capital Corp ATON.O:

ALPHATON CAPITAL EXECUTES BINDING CALL OPTION TO SELL LEGACY BIOTECH ASSET IOX THERAPEUTICS TO IMMUNOVA
ALPHATON CAPITAL CORP - TO RECEIVE CASH PAYMENT AND 10% EQUITY UPON ACQUISITION
ALPHATON CAPITAL CORP - TO RECEIVE $100 MILLION MILESTONE PAYMENTS AND ROYALTIES

Source text: ID:nGNX5ZmKBx

Further company coverage: ATON.O

((((Reuters.Briefs@thomsonreuters.com));))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2612462061"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2612462061\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2612462061?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-18 04:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612462061","market":"fut","top_or_hot":-1,"title":"BRIEF-Alphaton Capital Executes Binding Call Option With Immunova","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Alphaton Capital Executes Binding Call Option With Immunova</title></head><body><p><span>Feb 17 (Reuters)</span><span> - </span>AlphaTON Capital Corp <span>ATON.O</span>:</p><ul><li><p>ALPHATON CAPITAL EXECUTES BINDING CALL OPTION TO SELL LEGACY BIOTECH ASSET IOX THERAPEUTICS TO IMMUNOVA</p></li><li><p>ALPHATON CAPITAL CORP - TO RECEIVE CASH PAYMENT AND 10% EQUITY UPON ACQUISITION</p></li><li><p>ALPHATON CAPITAL CORP - TO RECEIVE $100 MILLION MILESTONE PAYMENTS AND ROYALTIES</p></li></ul><p>Source text: <span>ID:nGNX5ZmKBx</span></p><p>Further company coverage: <span>ATON.O</span></p><p> ((((Reuters.Briefs@thomsonreuters.com));))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Alphaton Capital Executes Binding Call Option With Immunova</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Alphaton Capital Executes Binding Call Option With Immunova\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-18 04:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Alphaton Capital Executes Binding Call Option With Immunova</title></head><body><p><span>Feb 17 (Reuters)</span><span> - </span>AlphaTON Capital Corp <span>ATON.O</span>:</p><ul><li><p>ALPHATON CAPITAL EXECUTES BINDING CALL OPTION TO SELL LEGACY BIOTECH ASSET IOX THERAPEUTICS TO IMMUNOVA</p></li><li><p>ALPHATON CAPITAL CORP - TO RECEIVE CASH PAYMENT AND 10% EQUITY UPON ACQUISITION</p></li><li><p>ALPHATON CAPITAL CORP - TO RECEIVE $100 MILLION MILESTONE PAYMENTS AND ROYALTIES</p></li></ul><p>Source text: <span>ID:nGNX5ZmKBx</span></p><p>Further company coverage: <span>ATON.O</span></p><p> ((((Reuters.Briefs@thomsonreuters.com));))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUAKLWCT:1","article_id":"2612462061","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2612462061","pubTimestamp":1771359435,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Alphaton Capital Executes Binding Call Option With ImmunovaFeb 17 (Reuters) - AlphaTON Capital Corp ATON.O:ALPHATON CAPITAL EXECUTES BINDING CALL OPTION TO SELL LEGACY BIOTECH ASSET IOX THERAPEU","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ATON":"AlphaTON Capital Corp."},"translate_title":"简介-Alphaton Capital与Immunova执行具有约束力的看涨期权期权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATON":0.9},"content_text":"BRIEF-Alphaton Capital Executes Binding Call Option With ImmunovaFeb 17 (Reuters) - AlphaTON Capital Corp ATON.O:ALPHATON CAPITAL EXECUTES BINDING CALL OPTION TO SELL LEGACY BIOTECH ASSET IOX THERAPEUTICS TO IMMUNOVAALPHATON CAPITAL CORP - TO RECEIVE CASH PAYMENT AND 10% EQUITY UPON ACQUISITIONALPHATON CAPITAL CORP - TO RECEIVE $100 MILLION MILESTONE PAYMENTS AND ROYALTIESSource text: ID:nGNX5ZmKBxFurther company coverage: ATON.O ((((Reuters.Briefs@thomsonreuters.com));))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,event","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}